Data / Drug companies / Vecuronium bromide
Vecuronium bromide: 10 companies and 20 products in the FDA NDC directory
Vecuronium bromide is listed in the FDA National Drug Code Directory by 10 companies, with 20 products in commercial distribution. 20 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, lyophilized, for solution; injection, powder, for solution; injection, and the newest product started marketing on December 5, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 20
- Generic (ANDA) products
- 20 (100.0%)
- Application numbers
- 6
- Routes
- Intravenous
- openFDA record search
- api.fda.gov
Companies that list vecuronium bromide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Eugia US LLC | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 20, 2018 |
| Gland Pharma Limited | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 30, 2016 |
| HF Acquisition Co LLC, DBA HealthFirst | 2 | injection, powder, lyophilized, for solution; injection, powder, for solution | Generic drugs (ANDA) | July 31, 2022 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, powder, for solution | Generic drugs (ANDA) | August 1, 2019 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 1, 2025 |
| Mullan Pharmaceutical Inc. | 2 | injection | Generic drugs (ANDA) | December 5, 2025 |
| Mylan Institutional LLC | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 19, 2015 |
| Sagent Pharmaceuticals | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 1, 2024 |
| Phlow Corporation | 1 | injection, powder, for solution | Generic drugs (ANDA) | August 1, 2019 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 14 | 70% |
| Injection, powder, for solution | 4 | 20% |
| Injection | 2 | 10% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 20 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nondepolarizing Neuromuscular Blocker | 20 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.